BioFIT at a glance
With the highest attending rate of academics, TTOs and research institutions, BioFIT is the place where academia-industry collaborations get started. BioFIT has taken on a whole new dimension becoming the meeting point in Europe for tech transfer and for sourcing early-stage innovations stemming from public research institutions, academic spin-offs and emerging biotech companies. Together with big pharma, biotech and diagnostic companies, BioFIT operates as a platform to build partnerships for all public and private actors. BioFIT is also the European marketplace for pre-seed, seed and Series A investment in Life Sciences.
>> SIGN UP NOW FOR BIOFIT 2022: Register now!
BioFIT & MedFIT 2021 key numbers
Who will you meet?
- TTOs / Research institutes / Academia - 30%
- Pharma / Diagnostic companies - 20%
- Biotech companies - 20%
- Preclinical CROs and CDMOs - 15%
- Investors - 10%
- Professional services, consulting and law firms - 5%
- CEO / VP / Managing Director - 35%
- Business Developer - 21%
- R&D Researcher / Scientist - 16%
- External collaborations / Licensing / Scouting / TTO - 14%
- Other - 14%